BMC Infectious Diseases

Table 4 The pre-transplant HBV status of the living donors and corresponding recipients and post-transplant treatment failure in the D(HBsAg+)/R(HBsAg-) group

From: Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients

HBsAg+ donor^a					HBsAg- recipients^b				Treatment failure
HBsAb	HBeAb	HBcAb	HBV DNA	No	HBsAb	HBeAb	HBcAb	No	HBV DNA - → +	HBsAg - → +	HBeAg - → +	HBeAb - → +	HBcAb - → +	Clinical liver injury	Graft loss	Recipient death	Total
-	+	+	-	55	+	+	+	20						1	1		1
					+	-	+	15						1		1	1
					+	+	-	1					1				1
					+	-	-	8				2	2	1			3
					-	+	+	2									0
					-	-	+	3									0
					-	-	-	6	1	1		1	1	1	1	2	3
-	+	+	+	22	+	+	+	7						1	1	1	2
					+	-	+	5				1					1
					+	-	-	4					2				2
					-	+	+	3						1	1		2
					-	-	-	3	1	1	1		1	2		1	2
-	-	+	-	3	+	-	-	1									0
					-	-	-	2									0
+	+	+	+	1	+	-	+	1									0
+	-	+	-	1	-	+	+	1									0
+	-	-	+	1	+	-	+	1									0

^a All HBsAg+ living donors were HBeAg- before donation
^b All HBsAg- recipients were HBeAg- and HBV DNA- before transplantation

Back to article page

ISSN: 1471-2334

Contact us

Submission enquiries: bmcinfectiousdiseases@biomedcentral.com
General enquiries: ORSupport@springernature.com